TP53 and breast cancer: As shown in Fig. 2b, the hotspot mutations (frequency higher than 2%) in Chinese breast cancer included PIK3CA p.H1047R (13%), AKT1 p.E17K (4%), KMT2C p.K2797fs (2%), and TP53 p.R248Q (2%).